Lasse Laaksonen
BoreniusBorenius is well known for handling disputes, commercial IP work, trade mark portfolio management and regulatory matters related to the food, data, pharmaceuticals and healthcare industries. Jointly leading the team is Ben Rapinoja, who heads up the IP department’s dispute resolution team and focuses on patent and trade mark matters; and Lasse Laaksonen, who steers the firm’s IP and commercial team, specialising in contentious and non-contentious IP and technology law. While Jemina Bonsdorff is well versed in IP litigation and technology and commercial contracts, Wilma Kivilä has extensive experience in the pharmaceuticals, healthcare and life sciences sectors.
Legal 500 Editorial commentary
Key clients
- Viatris
- Teva Pharmaceutical Industries
- Kesko Corporation
- Guangdong OPPO Mobile Telecommunications Corp., Ltd
- Sandvik
- Detection Technology Plc
- Lumene Ltd
- Aalto University Foundation
- SodaStream International B.V.
- STADA Arzneimittel AG
- Neuraxpharm
- O. Kavli AB
- Harvia Plc
- News Media Finland
Work highlights
- Representing Teva in a patent dispute relating to Bristol-Myers Squibb Holdings’ blockbuster Alzheimer disease drug Eliquis, seeking to invalidate the patent-in-suit on the basis of plausibility.
- Representing OPPO and its subsidiary OnePlus Technology in standard essential patent and FRAND litigation against Nokia Corporation relating to 4G/5G telecoms standard and FRAND license terms between the parties.
- Acted for Kesko Plc in multi-pronged trade mark litigation.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Ben Rapinoja
BoreniusPractice head
The lawyer(s) leading their teams.
Ben Rapinoja, Lasse Laaksonen